Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR)Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meetingheld today i.e. 14th November, 2024 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024.
Board Meeting Outcome for Board Meeting Held On 14Th November 2024
View original source (BSE India)Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Rekvina Laboratories Ltd. Press Release Nov 08 2024
- Board Meeting Intimation for Board Meeting To Be Held On 14Th November, 2024.
Later from Rekvina Laboratories
- Financial Result For Quarter And Half Year Ended On 30Th September 2024.
- Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2024.
- Rekvina Laboratories Ltd. Press Release Nov 14 2024
- Appointment of Company Secretary and Compliance Officer
- Rekvina Laboratories Ltd. Press Release Dec 04 2024
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories